Cancer Family
Pancreaticobiliary Neoplasm
CI-CAN-00000309Explore in graph →
Non-malignant1,205 active trials11 approved drugs92 evidence items
- NCIt
- C223357
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000309Explore in graph →
Clinical trials
5,005 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04002128 | Tracheal Colonization and Outcome After Major Abdominal Cancer Surgery | completed | N/A | 120 | Osijek University HospitalOTHER | 0 | Apr 23, 2024 | clinicaltrials |
| NCT06378853 | Risk Factors of Postoperative Complications and Survival Rate in Pancreatic Ductal Adenocarcinoma Patients | completed | — | 548 | Jinling Hospital, ChinaOTHER | 1 | Apr 23, 2024 | clinicaltrials |
| NCT06378580 | The Prognostic Impact of Surufatinib for the Treatment of Advanced Pancreatic Ductal Adenocarcinoma | completed | — | 72 | Luo CongOTHER | 1 | Apr 22, 2024 | clinicaltrials |
| NCT01931644 | At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions | completed | — | 17,667 | Sanguine BiosciencesINDUSTRY | 1 | Apr 18, 2024 | clinicaltrials |
| NCT04595058 | LAMS Choledochoduodenostomies: With or Without Coaxial Plastic Stent(BAMPI) | completed | N/A | 123 | Hospital Universitari de BellvitgeOTHER | 1 | Apr 18, 2024 | clinicaltrials |
| NCT06363084 | A Retrospective Study for Nimotuzumab Plus Postoperative Adjuvant Chemotherapy for Resectable Pancreatic Cancer | completed | — | 64 | Ruijin HospitalOTHER | 0 | Apr 12, 2024 | clinicaltrials |
| NCT01827553 | Pancreatic Carcinoma: Chemoradiation Compared With Chemotherapy Alone After Induction Chemotherapy(CONKO-007) | completed | Phase 3 | 830 | University of Erlangen-Nürnberg Medical SchoolOTHER | 1 | Apr 11, 2024 | clinicaltrials |
| NCT05191498 | Intratumoral Holmium Microspheres Brachytherapy for Patients With Pancreatic Cancer(SLOTH-1) | completed | N/A | 3 | Radboud University Medical CenterOTHER | 1 | Apr 11, 2024 | clinicaltrials |
| NCT06357117 | Extent of Intrahepatic Infiltration of Perihilar Cholangiocarcinoma | completed | — | 62 | Beijing Tsinghua Chang Gung HospitalOTHER | 1 | Apr 11, 2024 | clinicaltrials |
| NCT03201458 | Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer | completed | Phase 2 | 86 | National Cancer Institute (NCI)NIH | 1 | Apr 5, 2024 | clinicaltrials |
| NCT03490669 | Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid Tumors | completed | Phase 1 | 41 | AstraZenecaINDUSTRY | 3 | Apr 5, 2024 | clinicaltrials |
| NCT02395016 | A Study of Nimotuzumab Combinated With Gemcitabine in K-RAS Wild-type Locally Advanced and Metastatic Pancreatic Cancer | completed | Phase 3 | 90 | Biotech Pharmaceutical Co., Ltd.OTHER | 1 | Apr 4, 2024 | clinicaltrials |
| NCT04181645 | SHR- 1210 Combined With Paclitaxel (Albumin Bound) and Gemcitabine as First-line Therapy in Patients With Metastatic Pancreatic Cancer | completed | N/A | 40 | RenJi HospitalOTHER | 1 | Apr 3, 2024 | clinicaltrials |
| NCT05476978 | Artificial Intelligence in EUS for Diagnosing Pancreatic Solid Lesions | completed | — | 130 | Huazhong University of Science and TechnologyOTHER | 1 | Apr 3, 2024 | clinicaltrials |
| NCT01761240 | Dose Escalation Study MORAb-066 Targeting Tissue Factor (TF)-Expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC | completed | Phase 1 | 27 | MorphotekINDUSTRY | 1 | Mar 29, 2024 | clinicaltrials |
| NCT06336694 | A Deep Learning Radiomics Model for Predicting Occult Peritoneal Metastases of Pancreatic Adenocarcinoma | completed | — | 302 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Mar 29, 2024 | clinicaltrials |
| NCT03329950 | A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies | completed | Phase 1 | 132 | Celldex TherapeuticsINDUSTRY | 1 | Mar 28, 2024 | clinicaltrials |
| NCT04059562 | Trifluridine/Tipiracil in Combination With Irinotecan as a Second Line Therapy in Patients With Cholangiocarcinoma(TRITICC) | completed | Phase 2 | 28 | Heinrich-Heine University, DuesseldorfOTHER | 1 | Mar 27, 2024 | clinicaltrials |
| NCT03373188 | VX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal Cancer | completed | Phase 1 | 10 | Emory UniversityOTHER | 1 | Mar 20, 2024 | clinicaltrials |
| NCT06316908 | Permanent Celiac Plexus Block: Comparison of Pain Score in Unilateral and Bilateral Posterior Percutaneous Approach | completed | Phase 4 | 30 | Sindh Institute of Urology and TransplantationOTHER | 1 | Mar 19, 2024 | clinicaltrials |
| NCT04431258 | ABTL0812 in Combination With FOLFIRINOX for First-line Treatment of Metastatic Pancreatic Study(PanC-ASAP) | completed | Phase 1 / Phase 2 | 150 | Ability Pharmaceuticals SLINDUSTRY | 4 | Mar 18, 2024 | clinicaltrials |
| NCT03339843 | Multiorgan Metabolic Imaging Response Assessment of Abemaciclib(MiMe-A) | completed | Phase 2 | 85 | Jules Bordet InstituteOTHER | 2 | Mar 15, 2024 | clinicaltrials |
| NCT03665285 | A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors | completed | Phase 1 / Phase 2 | 109 | NextCure, Inc.INDUSTRY | 1 | Mar 8, 2024 | clinicaltrials |
| NCT04119362 | PARAGON Platform for Outcome, Quality of Life, and Translational Research on Pancreatic Cancer(PARAGON) | completed | — | 469 | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus NordwestOTHER | 1 | Mar 7, 2024 | clinicaltrials |
| NCT04617067 | Paricalcitol Trial: Phase II, Open Label Clinical Trial of Paricalcitol in Combination With Gemcitabine/ Nab-Paclitaxel Therapy in Advanced Pancreatic Cancer | completed | Phase 2 | 15 | Cancer Trials IrelandNETWORK | 1 | Mar 6, 2024 | clinicaltrials |
| NCT01466036 | Cabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid Tumors | completed | Phase 2 | 61 | Dana-Farber Cancer InstituteOTHER | 1 | Mar 5, 2024 | clinicaltrials |
| NCT02128100 | Effects of Folfirinox and Stereotactic Body Radiation Therapy for Advanced Pancreatic Cancer(BCC-RAD-13) | completed | Phase 2 | 5 | University of LouisvilleOTHER | 1 | Mar 5, 2024 | clinicaltrials |
| NCT00019006 | Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2024 | clinicaltrials |
| NCT06278493 | A Clinical Study of AL2846 Capsule Combined With Gemzar Injection in the Treatment of Advanced Pancreatic Cancer | completed | Phase 1 / Phase 2 | 34 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Feb 26, 2024 | clinicaltrials |
| NCT04177810 | Plerixafor and Cemiplimab in Metastatic Pancreatic Cancer | completed | Phase 2 | 25 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Feb 23, 2024 | clinicaltrials |
| NCT01673334 | Evaluation of EUS-Guided 22 Gauge Core Biopsy Versus Fine-needle Aspiration for Suspected Pancreatic Neoplasms | completed | Phase 4 | 40 | University of VirginiaOTHER | 1 | Feb 22, 2024 | clinicaltrials |
| NCT05161013 | A Proof-of-Concept Study Evaluating LINFU™ | completed | N/A | 12 | Adenocyte, LLCINDUSTRY | 1 | Feb 20, 2024 | clinicaltrials |
| NCT06254430 | Effects of Erector Spina Plan Block and Epidural Analgesia in Whipple Surgery | completed | — | 65 | Ankara City Hospital BilkentOTHER | 1 | Feb 20, 2024 | clinicaltrials |
| NCT06267690 | A CT-based Radiomics Model to Predict Survival-graded Fibrosis in PDAC | completed | — | 295 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Feb 20, 2024 | clinicaltrials |
| NCT04305067 | PRECISE: Pancreatic Cancer and Exercise | completed | N/A | 8 | Queen's University, BelfastOTHER | 1 | Feb 16, 2024 | clinicaltrials |
| NCT06258824 | MicroRNAs as Bile-based Biomarkers in Pancreaticobiliary Cancers(MIRABILE) | completed | — | 229 | Imperial College LondonOTHER | 1 | Feb 14, 2024 | clinicaltrials |
| NCT03834701 | Endoscopic Ultrasound-guided RadioFrequency Ablation for the Treatment Pancreatic NeuroEndocrine Neoplasms(RAPNEN) | completed | N/A | 60 | Catholic University of the Sacred HeartOTHER | 1 | Feb 13, 2024 | clinicaltrials |
| NCT01959139 | S1313, PEGPH20 in Treating Patients With Newly Diagnosed Metastatic Pancreatic Cancer | completed | Phase 1 / Phase 2 | 126 | SWOG Cancer Research NetworkNETWORK | 1 | Feb 9, 2024 | clinicaltrials |
| NCT04290364 | Early Palliative Care in Pancreatic Cancer - a Quasi-experimental Study(PanEffort-1) | completed | — | 74 | Inge Høgh DufvaOTHER | 1 | Feb 9, 2024 | clinicaltrials |
| NCT01525082 | Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors | completed | Phase 2 | 20 | Shaheen ShaguftaOTHER | 1 | Feb 6, 2024 | clinicaltrials |
| NCT05074472 | A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors | completed | Phase 1 / Phase 2 | 35 | ZielBio, Inc.INDUSTRY | 1 | Jan 29, 2024 | clinicaltrials |
| NCT04066361 | OPTimizing Treatment Focused Genetic Testing IN Cancer(OPT-IN) | completed | N/A | 301 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 25, 2024 | clinicaltrials |
| NCT04406571 | Reorganization of the Healthcare System During COVID-19 Pandemic: Impact on Management of Patients With Exocrine Pancreatic Cancer(CAPANCOVID-19) | completed | — | 700 | CHU de ReimsOTHER | 1 | Jan 24, 2024 | clinicaltrials |
| NCT04330716 | Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers(GeneBOPP) | completed | N/A | 269 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 19, 2024 | clinicaltrials |
| NCT04803305 | Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia | completed | Phase 1 | 18 | PfizerINDUSTRY | 2 | Jan 12, 2024 | clinicaltrials |
| NCT04624217 | A Trial of SHR-1701 in Combination With Gemcitabine and Albumin Paclitaxel in Patients With Pancreatic Cancer | completed | Phase 1 / Phase 2 | 56 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Jan 11, 2024 | clinicaltrials |
| NCT02539537 | A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic Carcinoma(NEOPAN) | completed | Phase 3 | 171 | UNICANCEROTHER | 1 | Jan 9, 2024 | clinicaltrials |
| NCT06195254 | Stereotactic Body Radiotherapy Combined With PD-1 Blockers for Locally Advanced or Locally Recurrent Pancreatic Cancer | completed | — | 19 | Peking University Third HospitalOTHER | 1 | Jan 8, 2024 | clinicaltrials |
| NCT00486356 | Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer | completed | Phase 1 | 46 | University of NebraskaOTHER | 1 | Jan 3, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Apr 23, 2024source: clinicaltrials